Laura Rueda-Gensini
Overview
Explore the profile of Laura Rueda-Gensini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rueda-Gensini L, Serna J, Rubio D, Orozco J, Bolanos N, Cruz J, et al.
Biofabrication
. 2023 Jun;
15(4).
PMID: 37369196
Parkinson's disease (PD) is a complex and multifaceted neurodegenerative disorder that results from multiple environmental factors and multicellular interactions. Although several PD neuropathologies have been identified and described, the thorough...
2.
Ravelo-Nieto E, Cifuentes J, Puentes P, Rueda-Gensini L, Quezada V, Ostos C, et al.
Front Bioeng Biotechnol
. 2023 May;
11:1184973.
PMID: 37229494
The limited delivery of cargoes at the cellular level is a significant challenge for therapeutic strategies due to the presence of numerous biological barriers. By immobilizing the Buforin II (BUF-II)...
3.
Cespedes-Valenzuela D, Sanchez-Renteria S, Cifuentes J, Gomez S, Serna J, Rueda-Gensini L, et al.
Front Bioeng Biotechnol
. 2022 Jul;
10:947616.
PMID: 35875496
Melanoma is an aggressive type of skin cancer that accounts for over 75% of skin cancer deaths despite comprising less than 5% of all skin cancers. Despite promising improvements in...
4.
Rueda-Gensini L, Serna J, Bolanos N, Rodriguez J, Cruz J, Munoz-Camargo C
Front Pharmacol
. 2022 Jul;
13:905347.
PMID: 35837292
Plant-derived products have gained considerable attention as inflammation modulators given the wide variety of anti-inflammatory phytochemicals reported to be present in plants and their limited side effects during prolonged exposure...
5.
Puentes P, Rueda-Gensini L, Valderrama N, Hernandez I, Gonzalez C, Daza L, et al.
Sci Rep
. 2022 May;
12(1):8434.
PMID: 35589824
Drug Discovery is an active research area that demands great investments and generates low returns due to its inherent complexity and great costs. To identify potential therapeutic candidates more effectively,...
6.
Torres C, Cifuentes J, Gomez S, Quezada V, Giraldo K, Puentes P, et al.
Pharmaceutics
. 2022 Feb;
14(2).
PMID: 35214047
Magnetite nanoparticles (MNPs) have gained significant attention in several applications for drug delivery. However, there are some issues related to cell penetration, especially in the transport of cargoes that show...
7.
Serna J, Rueda-Gensini L, Cespedes-Valenzuela D, Cifuentes J, Cruz J, Munoz-Camargo C
Polymers (Basel)
. 2021 Oct;
13(19).
PMID: 34641079
Due to their highly hydrophilic nature and compositional versatility, hydrogels have assumed a protagonic role in the development of physiologically relevant tissues for several biomedical applications, such as in vivo...
8.
Rueda-Gensini L, Serna J, Cifuentes J, Cruz J, Munoz-Camargo C
Int J Bioprint
. 2021 Jul;
7(3):353.
PMID: 34286147
Decellularized extracellular matrices (dECMs) have shown enormous potential for the biofabrication of tissues due to their biomimetic properties that promote enhanced cellular interaction and tissue regeneration. However, biofabrication schemes requiring...
9.
Rueda-Gensini L, Cifuentes J, Castellanos M, Puentes P, Serna J, Munoz-Camargo C, et al.
Nanomaterials (Basel)
. 2020 Sep;
10(9).
PMID: 32932957
Iron oxide nanoparticles (IONs) have been widely explored for biomedical applications due to their high biocompatibility, surface-coating versatility, and superparamagnetic properties. Upon exposure to an external magnetic field, IONs can...